SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (364)2/4/1999 4:18:00 PM
From: LLCF  Read Replies (2) | Respond to of 712
 
<If Integrilin will have a significant market presence, I do see CORR as a likely takeover target.>

I certainly agree... these guys think very financially... "stream of cash blah blah blah". The other stock the comes to mind immediately (I've been buying this one from $9 up) is CEPH... I know they have a disappointing past, but if Provigil takes off someone will buy 'em and kick the mngmt out anyway IMO. What you think of CEPH?

DAK



To: aknahow who wrote (364)3/5/1999 10:39:00 PM
From: LLCF  Read Replies (2) | Respond to of 712
 
<If sales really ramp >

Aren't we expecting to hear some sales numbers (Intergrelin) next week??

DAK